The Numbers
| Metric | Actual | Estimate | Result |
|---|---|---|---|
| EPS | $3.29 | $3.19 | ✅ Beat |
| Revenue | $18.7B | $18.05B | ✅ Beat |
Accenture reported fiscal Q4 2026 results before the opening bell on October 1, clearing both the top and bottom line. The beat landed well above the implied earnings move of ~8.5% that UBS had flagged pre-release (vs. a historical average of 4.3%), signaling the market had priced in real uncertainty heading into print.
Guidance Update
Management’s tone into the October 14 investor day turned more constructive, with several major banks (UBS among them) already warming on the stock in late September ahead of the print.
What Happened
✅ Positives:
- Clear double beat on EPS and revenue
- Stock surged 6.7% in pre-market trading, rebounding sharply off its 52-week low of $118.15
- UBS reiterated Buy rating, $275 price target
⚠️ Concerns:
- None material flagged in the immediate reaction — market read was unambiguously positive
Market Reaction
Shares advanced toward $195.60 in early trading, a sharp rebound from the 52-week low and one of the stronger single-day consulting-sector moves this year.
Bottom Line
Accenture’s double beat and resumed analyst confidence suggest the worst of the growth-scare narrative around enterprise IT/consulting spend may be behind it — watch the October 14 investor day for confirmation on forward guidance.